Clinical Trial Update: Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

View source ↗

Summary

This update reports that the clinical trial evaluating early response assessment in diffuse large B-cell lymphoma using FDG-PET has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Diffuse Large B-cell Lymphoma | Status: COMPLETED